ALNYLAM PHARMACEUTICALS, INC. Operating Income
ALNYLAM PHARMACEUTICALS, INC. (ALNY) reported Operating Income of $231.44 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-07-30
- ALNYLAM PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2026-06-30 was $231.44M.
- ALNYLAM PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2025-12-31 was $131.72M.
- ALNYLAM PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2025-09-30 was $367.98M.
- ALNYLAM PHARMACEUTICALS, INC. operating income (loss) for the quarter ending 2025-06-30 was -$16.20M, a 133.32% decline year-over-year.
- ALNYLAM PHARMACEUTICALS, INC. operating income (loss) for fiscal 2025 was $501.58M.
- ALNYLAM PHARMACEUTICALS, INC. operating income (loss) for fiscal 2024 was -$176.88M.
- ALNYLAM PHARMACEUTICALS, INC. operating income (loss) for fiscal 2023 was -$282.18M.
- ALNYLAM PHARMACEUTICALS, INC. operating income (loss) for fiscal 2022 was -$785.07M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $231.44M 10-Q · filed 2026-07-30 | $500.08M 10-Q · filed 2026-07-30 | ||
| 2025-12-31 | $131.72M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $499.70M derived: sum of 2 quarters · filed 2026-02-12 | $483.50M derived: sum of 3 quarters · filed 2026-07-30 | $501.58M 10-K · filed 2026-02-12 |
| 2025-09-30 | $367.98M 10-Q · filed 2025-10-30 | $351.78M derived: sum of 2 quarters · filed 2026-07-30 | $369.86M 10-Q · filed 2025-10-30 | $264.70M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | -$16.20M 10-Q · filed 2026-07-30 | $1.88M 10-Q · filed 2026-07-30 | -$103.28M derived: sum of 3 quarters · filed 2026-07-30 | -$180.19M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $18.08M 10-Q · filed 2025-05-01 | -$87.08M derived: sum of 2 quarters · filed 2026-02-12 | -$163.99M derived: sum of 3 quarters · filed 2026-02-12 | -$115.37M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-12-31 | -$105.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | -$182.06M derived: sum of 2 quarters · filed 2026-02-12 | -$133.45M derived: sum of 3 quarters · filed 2026-02-12 | -$176.88M 10-K · filed 2026-02-12 |
| 2024-09-30 | -$76.91M 10-Q · filed 2025-10-30 | -$28.29M derived: sum of 2 quarters · filed 2025-10-30 | -$71.73M 10-Q · filed 2025-10-30 | -$188.13M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-06-30 | $48.61M 10-Q · filed 2025-07-31 | $5.18M 10-Q · filed 2025-07-31 | -$111.22M derived: sum of 3 quarters · filed 2026-02-12 | $102.64M derived: sum of 4 quarters · filed 2026-02-12 |
| 2024-03-31 | -$43.44M 10-Q · filed 2025-05-01 | -$159.84M derived: sum of 2 quarters · filed 2026-02-12 | $54.03M derived: sum of 3 quarters · filed 2026-02-12 | -$175.80M derived: sum of 4 quarters · filed 2026-02-12 |
| 2023-12-31 | -$116.40M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $97.46M derived: sum of 2 quarters · filed 2026-02-12 | -$132.37M derived: sum of 3 quarters · filed 2026-02-12 | -$282.18M 10-K · filed 2026-02-12 |
| 2023-09-30 | $213.87M 10-Q · filed 2024-10-31 | -$15.96M derived: sum of 2 quarters · filed 2024-10-31 | -$165.77M 10-Q · filed 2024-10-31 | -$354.38M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-06-30 | -$229.83M 10-Q · filed 2024-08-01 | -$379.64M 10-Q · filed 2024-08-01 | -$568.25M derived: sum of 3 quarters · filed 2025-02-13 | -$826.29M derived: sum of 4 quarters · filed 2025-02-13 |
| 2023-03-31 | -$149.81M 10-Q · filed 2024-05-02 | -$338.42M derived: sum of 2 quarters · filed 2025-02-13 | -$596.46M derived: sum of 3 quarters · filed 2025-02-13 | -$788.15M derived: sum of 4 quarters · filed 2025-02-13 |
| 2022-12-31 | -$188.61M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | -$446.65M derived: sum of 2 quarters · filed 2025-02-13 | -$638.34M derived: sum of 3 quarters · filed 2025-02-13 | -$785.07M 10-K · filed 2025-02-13 |
| 2022-09-30 | -$258.04M 10-Q · filed 2023-11-02 | -$449.73M derived: sum of 2 quarters · filed 2023-11-02 | -$596.46M 10-Q · filed 2023-11-02 | -$791.02M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-06-30 | -$191.69M 10-Q · filed 2023-08-03 | -$338.42M 10-Q · filed 2023-08-03 | -$532.98M derived: sum of 3 quarters · filed 2024-02-15 | -$714.66M derived: sum of 4 quarters · filed 2024-02-15 |
| 2022-03-31 | -$146.73M 10-Q · filed 2023-05-04 | -$341.29M derived: sum of 2 quarters · filed 2024-02-15 | -$522.97M derived: sum of 3 quarters · filed 2024-02-15 | -$669.13M derived: sum of 4 quarters · filed 2024-02-15 |
| 2021-12-31 | -$194.56M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$376.24M derived: sum of 2 quarters · filed 2024-02-15 | -$522.40M derived: sum of 3 quarters · filed 2024-02-15 | -$708.65M 10-K · filed 2024-02-15 |
| 2021-09-30 | -$181.68M 10-Q · filed 2022-10-27 | -$327.84M derived: sum of 2 quarters · filed 2022-10-27 | -$514.09M 10-Q · filed 2022-10-27 | -$708.31M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$146.16M 10-Q · filed 2022-07-28 | -$332.41M 10-Q · filed 2022-07-28 | -$526.64M derived: sum of 3 quarters · filed 2023-02-23 | -$751.84M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | -$186.25M 10-Q · filed 2022-04-28 | -$380.48M derived: sum of 2 quarters · filed 2023-02-23 | -$605.67M derived: sum of 3 quarters · filed 2023-02-23 | -$804.53M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | -$194.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$419.42M derived: sum of 2 quarters · filed 2023-02-23 | -$618.28M derived: sum of 3 quarters · filed 2023-02-23 | -$828.44M 10-K · filed 2023-02-23 |
| 2020-09-30 | -$225.20M 10-Q · filed 2021-10-28 | -$424.06M derived: sum of 2 quarters · filed 2021-10-28 | -$634.22M 10-Q · filed 2021-10-28 | -$932.29M derived: sum of 4 quarters · filed 2022-02-10 |
| 2020-06-30 | -$198.86M 10-Q · filed 2021-08-03 | -$409.02M 10-Q · filed 2021-08-03 | -$707.09M derived: sum of 3 quarters · filed 2022-02-10 | -$923.39M derived: sum of 4 quarters · filed 2022-02-10 |
| 2020-03-31 | -$210.16M 10-Q · filed 2021-04-29 | -$508.23M derived: sum of 2 quarters · filed 2022-02-10 | -$724.53M derived: sum of 3 quarters · filed 2022-02-10 | -$960.80M derived: sum of 4 quarters · filed 2022-02-10 |
| 2019-12-31 | -$298.07M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-10 | -$514.37M derived: sum of 2 quarters · filed 2022-02-10 | -$750.64M derived: sum of 3 quarters · filed 2022-02-10 | -$939.43M 10-K · filed 2022-02-10 |
| 2019-09-30 | -$216.30M 10-Q · filed 2020-11-05 | -$452.57M derived: sum of 2 quarters · filed 2020-11-05 | -$641.36M 10-Q · filed 2020-11-05 | -$861.71M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-06-30 | -$236.27M 10-Q · filed 2020-08-06 | -$425.06M 10-Q · filed 2020-08-06 | -$645.41M derived: sum of 3 quarters · filed 2021-02-11 | -$899.97M derived: sum of 4 quarters · filed 2021-02-11 |
| 2019-03-31 | -$188.79M 10-Q · filed 2020-05-06 | -$409.14M derived: sum of 2 quarters · filed 2021-02-11 | -$663.70M derived: sum of 3 quarters · filed 2021-02-11 | -$856.06M derived: sum of 4 quarters · filed 2021-02-11 |
| 2018-12-31 | -$220.36M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11 | -$474.91M derived: sum of 2 quarters · filed 2021-02-11 | -$667.27M derived: sum of 3 quarters · filed 2021-02-11 | -$814.67M 10-K · filed 2021-02-11 |
| 2018-09-30 | -$254.56M 10-Q · filed 2019-10-31 | -$446.91M derived: sum of 2 quarters · filed 2019-10-31 | -$594.32M 10-Q · filed 2019-10-31 | -$741.62M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | -$192.35M 10-Q · filed 2019-08-06 | -$339.76M 10-Q · filed 2019-08-06 | -$487.06M derived: sum of 3 quarters · filed 2020-02-13 | -$612.86M derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | -$147.41M 10-Q · filed 2019-05-02 | -$294.71M derived: sum of 2 quarters · filed 2020-02-13 | -$420.51M derived: sum of 3 quarters · filed 2020-02-13 | -$540.98M derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | -$147.30M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$273.10M derived: sum of 2 quarters · filed 2020-02-13 | -$393.58M derived: sum of 3 quarters · filed 2020-02-13 | -$500.09M 10-K · filed 2020-02-13 |
| 2017-09-30 | -$125.80M 10-Q · filed 2018-11-07 | -$246.27M derived: sum of 2 quarters · filed 2018-11-07 | -$352.79M 10-Q · filed 2018-11-07 | -$468.22M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-06-30 | -$120.47M 10-Q · filed 2018-08-02 | -$226.99M 10-Q · filed 2018-08-02 | -$342.42M derived: sum of 3 quarters · filed 2019-02-14 | -$449.09M derived: sum of 4 quarters · filed 2019-02-14 |
| 2017-03-31 | -$106.51M 10-Q · filed 2018-05-04 | -$221.94M derived: sum of 2 quarters · filed 2019-02-14 | -$328.62M derived: sum of 3 quarters · filed 2019-02-14 | -$421.07M derived: sum of 4 quarters · filed 2019-02-14 |
| 2016-12-31 | -$115.43M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-14 | -$222.11M derived: sum of 2 quarters · filed 2019-02-14 | -$314.56M derived: sum of 3 quarters · filed 2019-02-14 | -$424.59M 10-K · filed 2019-02-14 |
| 2016-09-30 | -$106.68M 10-Q · filed 2017-11-07 | -$199.13M derived: sum of 2 quarters · filed 2017-11-07 | -$309.15M 10-Q · filed 2017-11-07 | -$401.67M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-06-30 | -$92.45M 10-Q · filed 2017-08-09 | -$202.48M 10-Q · filed 2017-08-09 | -$294.99M derived: sum of 3 quarters · filed 2018-02-15 | -$373.32M derived: sum of 4 quarters · filed 2018-02-15 |
| 2016-03-31 | -$110.03M 10-Q · filed 2017-05-05 | -$202.54M derived: sum of 2 quarters · filed 2018-02-15 | -$280.87M derived: sum of 3 quarters · filed 2018-02-15 | -$353.81M derived: sum of 4 quarters · filed 2018-02-15 |
| 2015-12-31 | -$92.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-15 | -$170.84M derived: sum of 2 quarters · filed 2018-02-15 | -$243.79M derived: sum of 3 quarters · filed 2018-02-15 | -$296.01M 10-K · filed 2018-02-15 |
| 2015-09-30 | -$78.33M 10-Q · filed 2016-11-03 | -$151.27M derived: sum of 2 quarters · filed 2016-11-03 | -$203.50M 10-Q · filed 2016-11-03 | -$249.21M derived: sum of 4 quarters · filed 2017-02-15 |
| 2015-06-30 | -$72.94M 10-Q · filed 2016-08-04 | -$125.17M 10-Q · filed 2016-08-04 | -$170.88M derived: sum of 3 quarters · filed 2017-02-15 | -$216.08M derived: sum of 4 quarters · filed 2017-02-15 |
| 2015-03-31 | -$52.22M 10-Q · filed 2016-05-04 | -$97.93M derived: sum of 2 quarters · filed 2017-02-15 | -$143.13M derived: sum of 3 quarters · filed 2017-02-15 | -$188.14M derived: sum of 4 quarters · filed 2017-02-15 |
| 2014-12-31 | -$45.71M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | -$90.91M derived: sum of 2 quarters · filed 2017-02-15 | -$135.92M derived: sum of 3 quarters · filed 2017-02-15 | -$404.98M 10-K · filed 2017-02-15 |
| 2014-09-30 | -$45.20M 10-Q · filed 2015-11-09 | -$90.20M derived: sum of 2 quarters · filed 2015-11-09 | -$359.27M 10-Q · filed 2015-11-09 | -$388.86M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-06-30 | -$45.01M 10-Q · filed 2015-08-07 | -$314.07M 10-Q · filed 2015-08-07 | -$343.66M derived: sum of 3 quarters · filed 2016-02-12 | -$375.89M derived: sum of 4 quarters · filed 2016-02-12 |
| 2014-03-31 | -$269.06M 10-Q · filed 2015-05-08 | -$298.66M derived: sum of 2 quarters · filed 2016-02-12 | -$330.89M derived: sum of 3 quarters · filed 2016-02-12 | -$352.20M derived: sum of 4 quarters · filed 2016-02-12 |
| 2013-12-31 | -$29.59M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-12 | -$61.83M derived: sum of 2 quarters · filed 2016-02-12 | -$83.14M derived: sum of 3 quarters · filed 2016-02-12 | -$92.94M 10-K · filed 2016-02-12 |
| 2013-09-30 | -$32.23M 10-Q · filed 2014-11-06 | -$53.55M derived: sum of 2 quarters · filed 2014-11-06 | -$63.35M 10-Q · filed 2014-11-06 | -$151.70M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-06-30 | -$21.31M 10-Q · filed 2014-08-08 | -$31.12M 10-Q · filed 2014-08-08 | -$119.47M derived: sum of 3 quarters · filed 2015-02-13 | -$137.61M derived: sum of 4 quarters · filed 2015-02-13 |
| 2013-03-31 | -$9.80M 10-Q · filed 2014-05-09 | -$98.15M derived: sum of 2 quarters · filed 2015-02-13 | -$116.30M derived: sum of 3 quarters · filed 2015-02-13 | -$128.37M derived: sum of 4 quarters · filed 2015-02-13 |
| 2012-12-31 | -$88.35M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-13 | -$106.50M derived: sum of 2 quarters · filed 2015-02-13 | -$118.56M derived: sum of 3 quarters · filed 2015-02-13 | -$129.46M 10-K · filed 2015-02-13 |
| 2012-09-30 | -$18.15M 10-Q · filed 2013-11-07 | -$30.21M derived: sum of 2 quarters · filed 2013-11-07 | -$41.11M 10-Q · filed 2013-11-07 | -$54.69M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-06-30 | -$12.07M 10-Q · filed 2013-08-09 | -$22.96M 10-Q · filed 2013-08-09 | -$36.55M derived: sum of 3 quarters · filed 2014-02-20 | -$48.98M derived: sum of 4 quarters · filed 2014-02-20 |
| 2012-03-31 | -$10.89M 10-Q · filed 2013-05-07 | -$24.48M derived: sum of 2 quarters · filed 2014-02-20 | -$36.92M derived: sum of 3 quarters · filed 2014-02-20 | -$50.03M derived: sum of 4 quarters · filed 2014-02-20 |
| 2011-12-31 | -$13.59M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | -$26.02M derived: sum of 2 quarters · filed 2014-02-20 | -$39.14M derived: sum of 3 quarters · filed 2014-02-20 | -$54.82M 10-K · filed 2014-02-20 |
| 2011-09-30 | -$12.44M 10-Q · filed 2012-11-05 | -$25.56M derived: sum of 2 quarters · filed 2012-11-05 | -$41.23M 10-Q · filed 2012-11-05 | -$53.64M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-06-30 | -$13.12M 10-Q · filed 2012-08-08 | -$28.79M 10-Q · filed 2012-08-08 | -$41.20M derived: sum of 3 quarters · filed 2013-02-19 | -$49.93M derived: sum of 4 quarters · filed 2013-02-19 |
| 2011-03-31 | -$15.68M 10-Q · filed 2012-05-03 | -$28.09M derived: sum of 2 quarters · filed 2013-02-19 | -$36.81M derived: sum of 3 quarters · filed 2013-02-19 | -$48.44M derived: sum of 4 quarters · filed 2013-02-19 |
| 2010-12-31 | -$12.41M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-19 | -$21.14M derived: sum of 2 quarters · filed 2013-02-19 | -$32.76M derived: sum of 3 quarters · filed 2013-02-19 | -$44.07M 10-K · filed 2013-02-19 |
| 2010-09-30 | -$8.73M 10-Q · filed 2011-11-03 | -$20.35M derived: sum of 2 quarters · filed 2011-11-03 | -$31.66M 10-Q · filed 2011-11-03 | -$39.73M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-06-30 | -$11.63M 10-Q · filed 2011-08-03 | -$22.93M 10-Q · filed 2011-08-03 | -$31.00M derived: sum of 3 quarters · filed 2012-02-13 | -$40.65M derived: sum of 4 quarters · filed 2012-02-13 |
| 2010-03-31 | -$11.31M 10-Q · filed 2011-05-05 | -$19.38M derived: sum of 2 quarters · filed 2012-02-13 | -$29.02M derived: sum of 3 quarters · filed 2012-02-13 | -$51.44M derived: sum of 4 quarters · filed 2012-02-13 |
| 2009-12-31 | -$8.07M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-13 | -$17.72M derived: sum of 2 quarters · filed 2012-02-13 | -$40.13M derived: sum of 3 quarters · filed 2012-02-13 | -$48.11M 10-K · filed 2012-02-13 |
| 2009-09-30 | -$9.65M 10-Q · filed 2010-11-04 | -$32.06M derived: sum of 2 quarters · filed 2010-11-04 | -$40.04M 10-Q · filed 2010-11-04 | |
| 2009-06-30 | -$22.41M 10-Q · filed 2010-08-05 | -$30.39M 10-Q · filed 2010-08-05 | ||
| 2008-12-31 | -$27.84M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |